Maria Gobbo is the latest recipient of the ALS fellowship named in his honour
In 2010, former Montreal Alouette and McGill physical education instructor Tony Proudfoot passed away from ALS. Ten years later, his legacy lives on in a fund that helps train and support the next generation of leaders fighting this disease.
Leading antibody reagent and knockout cell line manufacturers team up to address life science reproducibility crisis
YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, is pleased to announce the publication of its first characterization data and formation of its Industry Advisory Committee (IAC).
To make sense of complex environments, brain waves constantly adapt, compensating for drastically different sound and vision processing speeds
Every high-school physics student learns that sound and light travel at very different speeds. If the brain did not account for this difference, it would be much harder for us to tell where sounds came from, and how they are related to what we see.
Study uses sugar to make and deliver pudding-like brain implants that reduce foreign body response
Brain implants are used to treat neurological dysfunction, and their use for enhancing cognitive abilities is a promising field of research. Implants can be used to monitor brain activity or stimulate parts of the brain using electrical pulses. In epilepsy, for example, brain implants can determine where in the brain seizures are happening.
Brain Canada grant will aid research into neurodevelopmental, psychiatric, and neurodegenerative disorders
Electroencephalography (EEG) is an important tool in understanding the mechanism of brain disorders. Research in the field has gotten a major boost thanks to a $1.85M grant from Brain Canada to support EEGNet, an open repository for EEG data that helps scientists investigate neurodevelopmental, psychiatric, and neurodegenerative disorders.
Comparing two neural maps reveals the roles of genes in cognition, perception and feeling
Many psychiatric disorders have genetic causes, but the exact mechanism of how genes influence higher brain function remains a mystery. A new study provides a map linking the genetic signature of functions across the human brain, a tool that may provide new targets for future treatments.
The Canada Foundation for Innovation supports innovative projects that tackle global challenges
Exciting initiatives involving researchers at The Neuro are among the latest getting support under The Canada Foundation for Innovation’s Innovation Fund competition.
$4.67M from Brain Canada will help probe the brain’s mysteries and create international research links
Research at The Neuro’s McConnell Brain Imaging Centre (BIC) of McGill University will receive a major boost thanks to a $4.67M grant from Brain Canada’s Platform Support Grant (PSG) program.
Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease
Neural “signature” may reflect how we respond to feelings of social isolation
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Doctor has dedicated his life to improve diagnosis and treatment of neurological diseases and disorders
The Neuro’s director, Dr. Guy Rouleau, is being recognized with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care.
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro — Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Work will tell us how loneliness interacts with brain structure and function in normal aging and pre-symptomatic Alzheimer’s disease
Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.